Filters
New
Hikma celebrates 20 years on the London Stock Exchange
Story, Corporate
20 November 2025
New
Strategic priorities in Hikma Pharmaceuticals R&D: Q&A with Hafrun Fridriksdottir, EVP, Rx and R&D
Insight, Corporate
19 November 2025
New
Hikma signs an exclusive agreement with DGI Group to bring Claritag® to the MENA region
Press Release, Business Development
19 November 2025
New
Hikma confirms 2025 guidance and updates medium-term growth outlook
Press Release, Financial Results
06 November 2025
Hikma Pharmaceuticals announces the launch of STARJEMZA™ (ustekinumab-hmny) Injection, a biosimilar referencing STELARA®...
Press Release, Product
06 November 2025
New
Hikma R&D. Innovating Formulation Development. Meet Razan Alsawwaf
Story, Life at Hikma
05 November 2025
New
Hikma R&D. Innovating analytical development. Meet Edvin Brusač
Story, Life at Hikma
23 October 2025
New
Hikma R&D. Innovating formulation development. Meet Anas Abdull-kareem Younues
Story, Life at Hikma
15 October 2025
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA
Press Release, Business Development
06 October 2025
New
Inspiring women of Hikma - Meet Christine Schneider, General Manager, Hikma Germany
Story, Life at Hikma
06 October 2025
Driving pharmaceutical excellence and growth in Pavia: A Q&A with Roberto Gagliano, General Manager, Hikma Italia
Insight, Life at Hikma
03 October 2025
New
Hikma and Richter receive FDA approval for denosumab biosimilars EnobyTM (denosumab- qbde) and XtrenboTM (denosumab- qbd...
Press Release, Product
29 September 2025
New
Hikma R&D Innovating formulation development. Meet Helena Sremec
Story, Life at Hikma
29 September 2025
New
Inspiring women of Hikma. Meet Jaclyn Bachman, Associate Director Validations & Metrology, Cherry Hill, US
Story, Life at Hikma
16 September 2025
New
Hikma R&D Formulation Development Innovation. Meet Timothy Owen
Story, Life at Hikma
15 September 2025
You have viewed 15 of 539 results